7-92447800-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_021167.5(GATAD1):​c.71C>T​(p.Ala24Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000737 in 1,493,160 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A24P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000075 ( 0 hom. )

Consequence

GATAD1
NM_021167.5 missense

Scores

2
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.133

Publications

0 publications found
Variant links:
Genes affected
GATAD1 (HGNC:29941): (GATA zinc finger domain containing 1) The protein encoded by this gene contains a zinc finger at the N-terminus, and is thought to bind to a histone modification site that regulates gene expression. Mutations in this gene have been associated with autosomal recessive dilated cardiomyopathy. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jun 2012]
GATAD1 Gene-Disease associations (from GenCC):
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen
  • dilated cardiomyopathy 2B
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.13699988).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GATAD1NM_021167.5 linkc.71C>T p.Ala24Val missense_variant Exon 1 of 5 ENST00000287957.5 NP_066990.3 Q8WUU5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GATAD1ENST00000287957.5 linkc.71C>T p.Ala24Val missense_variant Exon 1 of 5 1 NM_021167.5 ENSP00000287957.3 Q8WUU5
TMBIM7PENST00000641474.1 linkn.14G>A non_coding_transcript_exon_variant Exon 1 of 10
GATAD1ENST00000645746.1 linkn.71C>T non_coding_transcript_exon_variant Exon 1 of 6 ENSP00000493785.1 A0A2R8Y4H1
GATAD1ENST00000644160.1 linkn.-74C>T upstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152132
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000106
AC:
1
AN:
94250
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000328
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000746
AC:
10
AN:
1341028
Hom.:
0
Cov.:
31
AF XY:
0.00000756
AC XY:
5
AN XY:
661538
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26832
American (AMR)
AF:
0.00
AC:
0
AN:
27798
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23384
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
74298
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47146
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5558
European-Non Finnish (NFE)
AF:
0.00000855
AC:
9
AN:
1052798
Other (OTH)
AF:
0.0000182
AC:
1
AN:
55040
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152132
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41432
American (AMR)
AF:
0.00
AC:
0
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68004
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.675
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Jan 03, 2017
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

A novel variant of uncertain significance has been identified in the GATAD1 gene. The A24V variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. It was not observed in approximately 4,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The A24V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Moreover, this substitution occurs at a position that is not conserved across species, and two of three in silico models predicts this variant likely does not alter the protein structure/function.Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign. This result cannot be interpreted for diagnosis or used for family member screening at this time. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.074
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0072
T
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.33
FATHMM_MKL
Benign
0.40
N
LIST_S2
Benign
0.71
T
M_CAP
Pathogenic
0.86
D
MetaRNN
Benign
0.14
T
MetaSVM
Uncertain
0.72
D
MutationAssessor
Benign
0.0
N
PhyloP100
0.13
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
-0.82
N
REVEL
Benign
0.28
Sift
Benign
0.23
T
Sift4G
Benign
0.28
T
Polyphen
0.015
B
Vest4
0.063
MutPred
0.26
Loss of helix (P = 0.079);
MVP
0.34
MPC
0.30
ClinPred
0.47
T
GERP RS
3.6
PromoterAI
-0.015
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.045
gMVP
0.12
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1057524462; hg19: chr7-92077114; API